Clinical application of radiotherapy in patients with oligometastatic ovarian cancer: a sharp tool to prolong the interval of systemic treatment
Abstract Background With the advances of radiation technology, treatment of oligometastatic disease, with limited metastatic burden, have more chances to achieve long-term local control. Here we aim to evaluate the efficacy and safety of radiotherapy (RT) in oligometastatic ovarian cancer patients....
Main Authors: | Jing Shen, Yinjie Tao, Lei He, Hui Guan, Hongnan Zhen, Zhikai Liu, Fuquan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-08-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00540-y |
Similar Items
-
Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients
by: Ming-Wei Ma, et al.
Published: (2022-10-01) -
Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
by: Tiuri E. Kroese, et al.
Published: (2022-11-01) -
Modern approach in oligometastatic prostate cancer therapy
by: Stanić Jelena, et al.
Published: (2023-01-01) -
Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma
by: Isabell Luisa Wahler, et al.
Published: (2023-12-01) -
Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)
by: Tae Hyung Kim, et al.
Published: (2022-11-01)